ARWR
Price
$20.18
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
27 days until earnings call
RVPH
Price
$1.20
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
13 days until earnings call
Ad is loading...

ARWR vs RVPH

Header iconARWR vs RVPH Comparison
Open Charts ARWR vs RVPHBanner chart's image
Arrowhead Pharmaceuticals
Price$20.18
Change-$0.00 (-0.00%)
Volume$850.54K
CapitalizationN/A
Reviva Pharmaceuticals Holdings
Price$1.20
Change-$0.00 (-0.00%)
Volume$223.55K
CapitalizationN/A
View a ticker or compare two or three
ARWR vs RVPH Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARWR vs. RVPH commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and RVPH is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ARWR: $20.18 vs. RVPH: $1.20)
Brand notoriety: ARWR: Notable vs. RVPH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 76% vs. RVPH: 64%
Market capitalization -- ARWR: $2.45B vs. RVPH: $47.65M
ARWR [@Biotechnology] is valued at $2.45B. RVPH’s [@Biotechnology] market capitalization is $47.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than RVPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while RVPH’s TA Score has 2 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 4 bearish.
  • RVPH’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than RVPH.

Price Growth

ARWR (@Biotechnology) experienced а -1.51% price change this week, while RVPH (@Biotechnology) price change was -20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ARWR is expected to report earnings on Feb 05, 2025.

RVPH is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.45B) has a higher market cap than RVPH($47.7M). ARWR YTD gains are higher at: -34.052 vs. RVPH (-76.699). RVPH has higher annual earnings (EBITDA): -36.24M vs. ARWR (-508.26M). ARWR has more cash in the bank: 434M vs. RVPH (6.18M). RVPH has less debt than ARWR: RVPH (208K) vs ARWR (118M). ARWR has higher revenues than RVPH: ARWR (19.6M) vs RVPH (0).
ARWRRVPHARWR / RVPH
Capitalization2.45B47.7M5,126%
EBITDA-508.26M-36.24M1,402%
Gain YTD-34.052-76.69944%
P/E RatioN/AN/A-
Revenue19.6M0-
Total Cash434M6.18M7,025%
Total Debt118M208K56,731%
FUNDAMENTALS RATINGS
ARWR vs RVPH: Fundamental Ratings
ARWR
RVPH
OUTLOOK RATING
1..100
413
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6390
P/E GROWTH RATING
1..100
218
SEASONALITY SCORE
1..100
8526

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVPH's Valuation (88) in the null industry is in the same range as ARWR (95) in the Biotechnology industry. This means that RVPH’s stock grew similarly to ARWR’s over the last 12 months.

RVPH's Profit vs Risk Rating (100) in the null industry is in the same range as ARWR (100) in the Biotechnology industry. This means that RVPH’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's SMR Rating (98) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that ARWR’s stock grew similarly to RVPH’s over the last 12 months.

ARWR's Price Growth Rating (63) in the Biotechnology industry is in the same range as RVPH (90) in the null industry. This means that ARWR’s stock grew similarly to RVPH’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is in the same range as RVPH (18) in the null industry. This means that ARWR’s stock grew similarly to RVPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARWRRVPH
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

RVPH and

Correlation & Price change

A.I.dvisor tells us that RVPH and GYRE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+5.26%
GYRE - RVPH
30%
Poorly correlated
+1.20%
TTNP - RVPH
29%
Poorly correlated
-0.88%
TNGX - RVPH
24%
Poorly correlated
-0.17%
ARWR - RVPH
23%
Poorly correlated
+0.40%
XENE - RVPH
23%
Poorly correlated
+0.02%
More